CC BY-NC-ND 4.0 · South Asian J Cancer 2017; 06(04): 150-168
DOI: 10.4103/sajc.sajc_145_17
Letter to the Editor

Musculoskeletal chronic graft versus host disease – A rare complication of allogeneic hematopoietic stem cell transplantation: A case report and review of its literature

Vasu Babu Goli
Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
,
Reetu Jain
Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
,
Ganapathi Bhat
Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
,
Anjana Sainani
Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
,
S. H. Advani
Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
› Author Affiliations
Source of Support: Nill.


Publication History

Article published online:
22 December 2020

© 2017. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Oda K, Nakaseko C, Ozawa S, Nishimura M, Saito Y, Yoshiba F, et al. Fasciitis and myositis: An analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant 2009;43:159-67.
  • 2 Openshaw H. Neurological manifestations of chronic graft versus hostdisease. In: Vogelsang GB, Pavletic SZ, editors. Chronic Graft Versuhost Disease. New York: Cambridge University Press; 2009. p. 243-51.
  • 3 Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT working party on late effects and EULEP study group on late effects. European group for blood and marrow transplantation. Ann Intern Med 1997;126:184-92.
  • 4 Min CK. The pathophysiology of chronic graft-versus-host disease: The unveiling of an enigma. Korean J Hematol 2011;46:80-7.
  • 5 Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006;12:31-47.
  • 6 Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
  • 7 Grauer O, Wolff D, Bertz H, Greinix H, Kühl JS, Lawitschka A, et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 2010;133:2852-65.